BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22189710)

  • 21. Polymorphisms of GSTP1 and related genes and prostate cancer risk.
    Beer TM; Evans AJ; Hough KM; Lowe BA; McWilliams JE; Henner WD
    Prostate Cancer Prostatic Dis; 2002; 5(1):22-7. PubMed ID: 15195126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C phosphorylation: an introduction.
    Parker PJ
    Methods Mol Biol; 2003; 233():159-62. PubMed ID: 12840505
    [No Abstract]   [Full Text] [Related]  

  • 23. The protein kinase C super-family member PKN is regulated by mTOR and influences differentiation during prostate cancer progression.
    Yang CS; Melhuish TA; Spencer A; Ni L; Hao Y; Jividen K; Harris TE; Snow C; Frierson HF; Wotton D; Paschal BM
    Prostate; 2017 Nov; 77(15):1452-1467. PubMed ID: 28875501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase C-delta and -epsilon: a functional appraisal.
    Olivier AR; Kiley SC; Pears C; Schaap D; Jaken S; Parker PJ
    Biochem Soc Trans; 1992 Aug; 20(3):603-7. PubMed ID: 1426597
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
    Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
    Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer.
    Jaggi M; Rao PS; Smith DJ; Wheelock MJ; Johnson KR; Hemstreet GP; Balaji KC
    Cancer Res; 2005 Jan; 65(2):483-92. PubMed ID: 15695390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRKCI negatively regulates autophagy via PIK3CA/AKT-MTOR signaling.
    Qu L; Li G; Xia D; Hongdu B; Xu C; Lin X; Chen Y
    Biochem Biophys Res Commun; 2016 Feb; 470(2):306-312. PubMed ID: 26792725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine phosphorylation of protein kinase C.
    Yamamoto T; Yamauchi E; Taniguchi H; Matsuzaki H; Kikkawa U
    Methods Mol Biol; 2003; 233():207-16. PubMed ID: 12840509
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic association between the PRKCH gene encoding protein kinase Ceta isozyme and rheumatoid arthritis in the Japanese population.
    Takata Y; Hamada D; Miyatake K; Nakano S; Shinomiya F; Scafe CR; Reeve VM; Osabe D; Moritani M; Kunika K; Kamatani N; Inoue H; Yasui N; Itakura M
    Arthritis Rheum; 2007 Jan; 56(1):30-42. PubMed ID: 17195206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
    Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells.
    Sumitomo M; Ohba M; Asakuma J; Asano T; Kuroki T; Asano T; Hayakawa M
    J Clin Invest; 2002 Mar; 109(6):827-36. PubMed ID: 11901191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical protein kinase C phosphorylates IKKalphabeta in transformed non-malignant and malignant prostate cell survival.
    Win HY; Acevedo-Duncan M
    Cancer Lett; 2008 Nov; 270(2):302-11. PubMed ID: 18571841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The family of protein kinase C: its molecular heterogeneity and differential expression.
    Kikkawa U; Ogita K; Shearman MS; Ase K; Sekiguchi K; Naor Z; Kishimoto A; Nishizuka Y; Saito N; Tanaka C
    Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 1():97-102. PubMed ID: 3254781
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression and purification of protein kinase Cdelta from bacteria.
    Gschwendt M; Stempka L
    Methods Mol Biol; 2003; 233():35-42. PubMed ID: 12840496
    [No Abstract]   [Full Text] [Related]  

  • 35. Animal models in the study of protein kinase C isozymes.
    Choi DS; Messing RO
    Methods Mol Biol; 2003; 233():455-73. PubMed ID: 12840529
    [No Abstract]   [Full Text] [Related]  

  • 36. CYP17 gene promoter allelic variant is not associated with prostate cancer.
    Lin CC; Wu HC; Chen WC; Chen HY; Tsai FJ
    Urol Oncol; 2003; 21(4):262-5. PubMed ID: 12954495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assignment of PRKCI to bovine chromosome 1q34-->q36 by FISH suggests a new assignment to human chromosome 3.
    De Donato M; Gallagher DS; Davis SK; Stelly DM; Taylor JF
    Cytogenet Cell Genet; 2001; 95(1-2):79-81. PubMed ID: 11978974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the role of protein kinase C isozymes in colon carcinogenesis using transgenic mouse models.
    Fields AP; Murray NR; Gustafson WC
    Methods Mol Biol; 2003; 233():539-53. PubMed ID: 12840533
    [No Abstract]   [Full Text] [Related]  

  • 39. PDK-1 and protein kinase C phosphorylation.
    Toker A
    Methods Mol Biol; 2003; 233():171-89. PubMed ID: 12840507
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma.
    Kim KH; Chung C; Kim JM; Lee D; Cho SY; Lee TH; Cho HJ; Yeo MK
    BMC Cancer; 2019 Aug; 19(1):804. PubMed ID: 31412817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.